Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19 Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05844202
What this trial is testing

Safety, Tolerability and Immunogenicity of Alveavax-v1.2, a BA.2/Omicron-optimized, DNA Vaccine for COVID-19 Prevention

Who this might be right for
Sars-CoV-2 Infection
Alvea Holdings, LLC 130
Large-scale testing (Phase 3)UnknownNCT04954092
What this trial is testing

Study of Gam-COVID-Vac in Adolescents

Who this might be right for
Covid19Vaccine Preventable Disease
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 3,000
Large-scale testing (Phase 3)Ended earlyNCT05683600
What this trial is testing

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd. 3,000
Post-approval studies (Phase 4)UnknownNCT04639375
What this trial is testing

Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19)

Who this might be right for
SARS-CoV-2
E-MO Biology Inc 300
Testing effectiveness (Phase 2)Study completedNCT04568031
What this trial is testing

Study of AZD1222 for the Prevention of COVID-19 in Japan

Who this might be right for
COVID-19
AstraZeneca 256
Not applicableUnknownNCT04824651
What this trial is testing

Covid-19 Vaccine Cohort in Specific Populations

Who this might be right for
Immune Deficiency
ANRS, Emerging Infectious Diseases 6,920
Large-scale testing (Phase 3)Study completedNCT04649151
What this trial is testing

Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 4,328
Not applicableStudy completedNCT06761612
What this trial is testing

Retail COVID-19 Study

Who this might be right for
COVID - 19
Biomedical Advanced Research and Development Authority 2,519
Large-scale testing (Phase 3)Study completedNCT04672395
What this trial is testing

A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19

Who this might be right for
COVID-19
Clover Biopharmaceuticals AUS Pty 31,454
Large-scale testing (Phase 3)Study completedNCT04838795
What this trial is testing

Sisonke (Together): OPEN LABEL TRIAL COVID-19

Who this might be right for
SARS (Severe Acute Respiratory Syndrome)
Wits Health Consortium (Pty) Ltd 477,102
Post-approval studies (Phase 4)Study completedNCT05028361
What this trial is testing

Simultaneous mRNA COVID-19 and IIV4 Vaccination Study

Who this might be right for
Quality of LifeInjection Site ReactionAdverse Drug Event+1 more
Duke University 348
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07390968
What this trial is testing

Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Patients

Who this might be right for
Hematopoietic and Lymphatic System Neoplasm
Fred Hutchinson Cancer Center 56
Not applicableStudy completedNCT05633927
What this trial is testing

Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed

Who this might be right for
SARS-CoV-2 RNA VaccinesHIV Infection
Hospitales Universitarios Virgen del Rocío 48
Not applicableStudy completedNCT06603090
What this trial is testing

Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season

Who this might be right for
InfluenzaCOVID-19Vaccination Hesitancy
Columbia University 66,147
Testing effectiveness (Phase 2)UnknownNCT04398147
What this trial is testing

Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada

Who this might be right for
COVID-19
CanSino Biologics Inc. 696
Early research (Phase 1)Study completedNCT04449276
What this trial is testing

Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Who this might be right for
Severe Acute Respiratory SyndromeCoronavirusSARS-CoV-2+1 more
CureVac 280
Not applicableUnknownNCT04809948
What this trial is testing

Effects of COVID 19 Vaccine on Egyptian Population

Who this might be right for
COVID 19 Vaccine
Assiut University 800
Testing effectiveness (Phase 2)UnknownNCT05873374
What this trial is testing

Evaluation of Safety, Tolerability, Reactogenicity, Immunogenicity of Baiya SARS-CoV-2 Vax 2 as a Booster for COVID-19

Who this might be right for
COVID-19 VaccineCOVID-19
Baiya Phytopharm Co., Ltd. 75
Testing effectiveness (Phase 2)Study completedNCT05827926
What this trial is testing

MRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults

Who this might be right for
SARS-CoV-2Influenza
ModernaTX, Inc. 1,758
Early research (Phase 1)Study completedNCT04691947
What this trial is testing

Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC

Who this might be right for
COVID-19 Vaccine
Health Institutes of Turkey 44
Next Page